Company / Free Cash Flow
Relay Therapeutics, Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$235.9M
FY2025
5-year range
-$304.4M / -$74.1M
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
#158 of 194
Health Care
What the data says
Relay Therapeutics, Inc.'s free cash flow of -$236M is lower than 81% of companies in the Health Care sector (FY2025). Improved from -$304M to -$236M over the past 2 years.
Based on SEC 10-K filings.
-$236M in FY2025.
Improved from -$304M to -$236M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 194This company -$235.9M Sector average $470.8M
▼
-150.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 6.1% year-over-year.
- Ranks #158 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$235.9M | +6.1% |
| FY2024 | -$251.1M | +17.5% |
| FY2023 | -$304.4M | -191.6% |
| FY2022 | -$104.4M | -40.9% |
| FY2021 | -$74.1M | +0.0% |
| FY2020 | -$74.1M | +0.0% |
| FY2019 | -$74.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026